What Are the Challenges of Anti-Angiogenic Therapies?
Despite their potential, anti-angiogenic therapies face several challenges. Tumors can develop resistance to these treatments by activating alternative angiogenic pathways or by increasing the invasive and metastatic capabilities of cancer cells. Additionally, the normalization of blood vessels induced by these therapies can sometimes paradoxically improve the delivery of other drugs to the tumor.
